Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients
- 6 January 2009
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 53 (1), 24-29
- https://doi.org/10.1016/j.jacc.2008.08.071
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Losartan and Prevention of Atrial Fibrillation Recurrence in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 2006
- Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor BlockersJournal of the American College of Cardiology, 2005
- Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) studyJournal of the American College of Cardiology, 2005
- Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockersJournal of the Renin-Angiotensin-Aldosterone System, 2004
- Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillationJournal of the American College of Cardiology, 2004
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJama-Journal Of The American Medical Association, 2003
- Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular DysfunctionCirculation, 1999
- ACE inhibitors and arrhythmiasHeart, 1996
- LONE AURICULAR FIBRILLATIONHeart, 1954